326030 2026-08-27 Biohaven: Sale Of Opakalim Rights To SK Biopharmaceuticals Makes Sense On Many Levels
Edmund Ingham 5 clicksKRX
Sk Biopharmaceuticals Co Ltd
326030
1 article
$5.1B Market cap · 2026-09-01
326030 2026-08-27 Edmund Ingham 5 clicksTickers on this page
Companies the articles above are also about, besides 326030.
